mahendras

| Join Mahendras Telegram Channel | Like Mahendras Facebook Page | Online Admission | Download Mahendras App

Now Subscribe for Free videos

Subscribe Now

English Language Quiz For IBPS | RBI | SBI | NABARD | LIC | 14-06-2024

Mahendra Guru





Dear Readers,


Mahendras has started special quizzes for IBPS | RBI | SBI | NABARD | LIC so that you can practice more and more to crack the examination. This IBPS | RBI | SBI | NABARD | LIC Exam special quiz series will mould your preparations in the right direction, and the regular practice of these quizzes will be very helpful in scoring good marks in the Examination. Here we are providing you with the critical question of English Language for the IBPS | RBI | SBI | NABARD | LIC.

Q.1-5. In the following passage there are blanks each of which has been numbered. These numbers are given below the passage and against each, three words have been suggested. Find out the appropriate word(s) in each case and mark your answer accordingly.

Russia’s candidate vaccine for COVID-19 appears to have found a midwife in India. The Russian Direct Investment Fund (RDIF), which is piloting the Sputnik V vaccine, has announced a partnership with the Hyderabad-based Dr. Reddy’s Laboratories to conduct a Phase-3 trial, or large multi-location human trials here. (P) _________ the candidate vaccine, developed by Russia’s Gamaleya, to prove safe and efficacious, the RDIF would supply 100 million doses through its partnership with Dr. Reddy’s Laboratories. However, there is no agreement to manufacture the vaccine here unlike the deal between the Pune-based Serum Institute of India and the United Kingdom-based AstraZeneca, for the Oxford University-developed ChAdOx1 vaccine. Sputnik V is being developed as a two-dose vaccine on a human adenovirus vaccine platform. Several vaccines that are in development are also being deployed on similar platforms, and the evidence so far is that none of these has been commercially approved for use in humans though there is an experimental vaccine for Ebola. Results of the Phase-1 and Phase-2 trials of the vaccine, published in The Lancet, suggest that the evidence so far is that it has proven safe and efficacious enough to progress to the next stage of trials. Controversially, Sputnik V has been granted a pre-approval by Russia’s regulators even before Phase-3 trials have been completed. There is (Q) _________ political pressure globally on regulatory agencies to get a vaccine out at the earliest. Thus, it is incumbent on a company conducting such trials to be particularly vigilant that all good practices and necessary protocols are (R) _________ followed. It is well acknowledged that two-thirds of the most common vaccines produced globally are made in India. The Serum Institute has committed to producing 100 million doses of its vaccine for India and other ‘Low and Middle Income Countries’ at less than $3 per dose. Reportedly, half of these are for India.
All in all, there seems to be a guarantee for only about 150 million doses for India, which given the country’s population is (S)_________. All of this of course does not account for the vaccines that are being indigenously developed in India: Covaxin, by Bharat Biotech, based on a strain sourced from the Indian Council of Medical Research, and ZyCov-D, the plasmid DNA-vaccine being developed by Zydus Cadilla. In Phase-2 trials now, both are being tested for their ability to produce a satisfactory(T)_________ response.


Q-1 Choose the correct option for (P).

A. Had

B. Provided

C. Were

(1) Only B 

(2) Both B and C

(3) Both A and B 

(4) Both A and C

(5) Only C

Q-2 Choose the correct option for (Q).

A. Immense

B. Excessive

C. Restricted

(1) Only B 

(2) Both B and C

(3) Both A and B

 (4) Both A and C

(5) Only C

Q-3 Choose the correct option for (R).

A. Scrupulously

B. Impetuously

C. Meticulously

(1) Only B

 (2) Both B and C

(3) Both A and B 

(4) Both A and C

(5) Only C

Q-4 Choose the correct option for (S).

A. miniscule

B. significant

C. miniature

(1) Only B 

(2) Both B and C

(3) Both A and B 

(4) Both A and C

(5) Only C

Q-5 Choose the correct option for (T).

A. immunity

B. immune

C. antibodies

(1) Only B

 (2) Both B and C

(3) Both A and B 

(4) Both A and C

(5) Only C

Q.6-10. In each of the following questions, a sentence with a blank has been given. You are given three words as answer choices and from those you have to pick up the correct word(s) to fill in the blank.

Q-6 India has the capabilities for vaccine manufacture, storage and distribution in reasonable time, but the vaccines must go through their ____________long gestation to ensure safety.

A. Inevitably

B. Unavoidable

C. Prescribed

(1) Only A 

(2) Only B

(3) Only C 

(4) Both A and B

(5) Both A and C

7-The News Broadcasters Association (NBA) has told the Supreme Court to make its code of ethics against airing malicious, biased and __________content applicable to all TV news channels.

A. regressive

B. derogatory

C. progressive

(1) Only A

 (2) Only B

(3) Only C

 (4) Both A and B

(5) Both A and C

Q-8The NBA suggested that the court direct the government to include its __________code in the Programme Code of the Cable Television Networks Rules, 1994.

A. ethical

B.virtuous

C. licentious

(1) Only A 

(2) Only B

(3) Only C 

(4) Both A and B

(5) Both A & C

Q-9 “Amendment of clause (c) of sub-section (1) of section 3 to include public servant also within its ________, to provide that no foreign contribution shall be accepted by any public servant,” the Bill says.

A. ambit

B.horizon

C. extent

(1) Only A

 (2) Only B

(3) Only C 

(4) Both A and C

(5) Both B and C

Q-10 New regulations put _________conditions on civil society organisations, and educational and research institutions that have partnerships, i n c l u d i n g o f a f i n a n c i a l n a t u r e , w i t h foreign entities.

A. onerous

B. facile

C. excessive

(1) Only A 

(2) Only B

(3) Both A and B

 (4) Both A and C

(5) Both B & C

ANSWER-

Q.1. (5)

Q.2. (3)

Q.3. (4)

Q.4. (4)

Q.5. (1)

Q.6. (1)

Q.7. (4)

Q.8. (4)

Q.9. (4)

Q.10. (4)

0 comments:

Post a Comment

MAHENDRA GURU

Copyright © 2023 www.mahendraguru.com All Right Reserved by Mahendra Educational Pvt . Ltd.